Ro 5-3335

Pricing Availability   Qty
Description: Core binding factor inhibitor; attenuates hematopoiesis
Alternative Names: CBFβ-Runx1 inhibitor II
Chemical Name: 7-Chloro-1,3-dihydro-5-(1H-pyrrol-2-yl)-2H-1,4-benzodiazepin-2-one
Purity: ≥98% (HPLC)
Datasheet
Citations (2)
Reviews

Biological Activity for Ro 5-3335

Ro 5-3335 is a core binding factor (CBF) inhibitor; preferentially kills human leukemia cell lines with CBF fusion proteins (IC50 = 1.1 μM). Represses RUNX1/CBFβ-dependent transactivation in reporter assays and inhibits transcriptional regulation by RUNX1 and CBFβ. Reduces leukemia burden in a mouse model. Attenuates RUNX1-dependent hematopoiesis in zebrafish embryos. Also a Tat antagonist; inhibits HIV-1 replication in vitro.

Compound Libraries for Ro 5-3335

Ro 5-3335 is also offered as part of the Tocriscreen 2.0 Max and Tocriscreen Antiviral Library. Find out more about compound libraries available from Tocris.

Technical Data for Ro 5-3335

M. Wt 259.69
Formula C13H10ClN3O
Storage Store at +4°C
Purity ≥98% (HPLC)
CAS Number 30195-30-3
PubChem ID 64983
InChI Key XWNMORIHKRROGW-UHFFFAOYSA-N
Smiles O=C1CN=C(C3=CC=CN3)C2=C(C=CC(Cl)=C2)N1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for Ro 5-3335

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 25.96 100

Preparing Stock Solutions for Ro 5-3335

The following data is based on the product molecular weight 259.69. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 3.85 mL 19.25 mL 38.51 mL
5 mM 0.77 mL 3.85 mL 7.7 mL
10 mM 0.39 mL 1.93 mL 3.85 mL
50 mM 0.08 mL 0.39 mL 0.77 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

Product Datasheets for Ro 5-3335

Certificate of Analysis / Product Datasheet
Select another batch:

References for Ro 5-3335

References are publications that support the biological activity of the product.

Cunningham et al (2012) Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBF beta interaction. Proc.Natl.Acad.Sci.USA 109 14592 PMID: 22912405

Cupelli et al (1995) The human immunodeficiency virus type 1 Tat antagonist, Ro 5-3335, predominantly inhibits transcription initiation from the viral promoter. J.Virol. 69 2640 PMID: 7884917

Okuda et al (2001) RUNX1/AML1: a central player in hematopoiesis. Int. J. Hematol. 74 252 PMID: 11721959


If you know of a relevant reference for Ro 5-3335, please let us know.

View Related Products by Target

View Related Products by Product Action

View all Other Transcription Factor Inhibitors

Keywords: Ro 5-3335, Ro 5-3335 supplier, Ro5-3335, CBF, core, binding, factor, Leukemia, inhibitors, inhibits, runt-related, transcription, 1, RUNX1, acute, myeloid, leukemia, protein, AML1, CBFβ, CBFα, hematopoiesis, HIV-1, replication, antiviral, CBFβ-Runx1, II, CBFbeta-Runx1, inhibitor, Other, Transcription, Factors, 4694, Tocris Bioscience

2 Citations for Ro 5-3335

Citations are publications that use Tocris products. Selected citations for Ro 5-3335 include:

Luo et al (2016) Runt-related Transcription Factor 1 (RUNX1) Binds to p50 in Macrophages and Enhances TLR4-triggeredInflammation and Septic Shock. Journal of Biological Chemistry PMID: 27573239

Jean Y et al (2022) LY6D marks pre-existing resistant basosquamous tumor subpopulations. Nat Commun 13 7520 PMID: 36473848


Do you know of a great paper that uses Ro 5-3335 from Tocris? Please let us know.

Reviews for Ro 5-3335

There are currently no reviews for this product. Be the first to review Ro 5-3335 and earn rewards!

Have you used Ro 5-3335?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review